三叶草生物-B(02197)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02197 三叶草生物-B

未开盘 04-02 16:08:19

2.850

+0.000

0.00%

最高3.040	最低2.790	成交量1,073万
今开2.830	昨收2.850	日振幅8.77%
总市值36.99亿	流通市值36.99亿	总股本12.98亿
成交额3,140万	换手率0.83%	流通股本12.98亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02197","market":"HK","secType":"STK","nameCN":"三叶草生物-B","latestPrice":2.85,"timestamp":1775117299579,"preClose":2.85,"halted":0,"volume":10726601,"delay":0,"changeRate":0,"floatShares":1298000000,"shares":1298000000,"eps":-0.18576481461862748,"marketStatus":"未开盘","change":0,"latestTime":"04-02 16:08:19","open":2.83,"high":3.04,"low":2.79,"amount":31404609,"amplitude":0.087719,"askPrice":2.85,"askSize":3500,"bidPrice":2.84,"bidSize":8500,"shortable":0,"etf":0,"ttmEps":-0.18576481461862748,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1775611800000},"marketStatusCode":0,"adr":0,"listingDate":1636041600000,"exchange":"SEHK","adjPreClose":2.85,"openAndCloseTimeList":[[1775093400000,1775102400000],[1775106000000,1775116800000]],"volumeRatio":1.247047177291092,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02197","defaultTab":"news","newsList":[{"id":"2623630863","title":"三叶草生物-B(02197)：完成呼吸道合胞病毒(RSV) + 人偏肺病毒(hMPV) + 副流感病毒3型 (PIV3) 呼吸道联合疫苗候选产品澳洲II期临床试验受试者招募","url":"https://stock-news.laohu8.com/highlight/detail?id=2623630863","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623630863?lang=zh_cn&edition=full","pubTime":"2026-03-30 06:19","pubTimestamp":1774822765,"startTime":"0","endTime":"0","summary":"智通财经APP讯，三叶草生物-B 发布公告，评估公司自研专有的呼吸道联合疫苗候选产品 SCB1022  及 SCB1033  的澳洲II期临床试验已完成受试者招募。叁叶草生物RSV联合疫苗候选产品进行中的II期是一项随机、观察者单盲、多中心研究的临床试验， 在澳洲招募420名老年受试者，受试者随机配接种 SCB1022、 SCB1033或安慰剂。该临床试验评估公司RSV联合候选疫苗产品的安全性、反应原性与免疫原性，预计于2026 年第三季获得初步结果。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1421401.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02197","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622821534","title":"三叶草生物-B(02197)授出1019.55万份购股权及896.5万个受限制股份单位","url":"https://stock-news.laohu8.com/highlight/detail?id=2622821534","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622821534?lang=zh_cn&edition=full","pubTime":"2026-03-27 20:38","pubTimestamp":1774615127,"startTime":"0","endTime":"0","summary":"智通财经APP讯，三叶草生物-B(02197)发布公告，于2026年3月27日，公司根据首次公开发售后购股权计划及受限制股份单位计划的条款分别向若干合资格参与者授出合共1019.55万份购股权及896.5万个受限制股份单位。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1420813.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02197","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198309307","title":"异动解读 | 三叶草生物-B盘中大涨5.32%，全年亏损大幅收窄提振股价","url":"https://stock-news.laohu8.com/highlight/detail?id=1198309307","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1198309307?lang=zh_cn&edition=full","pubTime":"2026-03-26 09:59","pubTimestamp":1774490379,"startTime":"0","endTime":"0","summary":"三叶草生物-B今日盘中股价大幅上涨5.32%，引起了市场的关注。消息面上，公司发布了截至2025年12月31日止的年度业绩报告。报告显示，公司全年净亏损为2.05亿元人民币，较上年同期的9.03亿元大幅收窄77.3%；若以非国际财务报告准则计，经调整年内亏损为1.98亿元，上年同期为8.87亿元。尽管公司收入同比大幅下滑，但亏损状况的显著改善，被市场视为积极的财务信号，这可能是推动股价在交易时段内走强的主要原因。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02197"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1182919544","title":"异动解读 | 年度业绩显示收入暴跌90.9%，三叶草生物-B盘中大跌5.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=1182919544","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1182919544?lang=zh_cn&edition=full","pubTime":"2026-03-26 09:34","pubTimestamp":1774488854,"startTime":"0","endTime":"0","summary":"三叶草生物-B今日盘中股价大跌5.32%，市场表现受到其最新发布的财务数据显著影响。消息面上，公司于盘前发布了截至2025年12月31日止年度的业绩报告。报告显示，公司年度收入仅为人民币350.5万元，同比大幅下滑90.9%。此外，公司现金及银行结余也从上一年度的约5.57亿元减少至约2.71亿元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02197"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622589883","title":"三叶草生物-B(02197)发布年度业绩 净亏损2.05亿元 同比收窄77.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2622589883","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622589883?lang=zh_cn&edition=full","pubTime":"2026-03-26 07:13","pubTimestamp":1774480415,"startTime":"0","endTime":"0","summary":"智通财经APP讯，三叶草生物-B(02197)发布截至2025年12月31日止年度业绩，集团收入人民币350.5万元，同比减少90.88%;研发开支1.82亿元，同比减少0.57%;净亏损2.05亿元，同比收窄77.3%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1419176.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02197","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1196681623","title":"三叶草生物-B 2025年收入下降，年内亏损显著收窄","url":"https://stock-news.laohu8.com/highlight/detail?id=1196681623","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1196681623?lang=zh_cn&edition=full","pubTime":"2026-03-26 06:20","pubTimestamp":1774477209,"startTime":"0","endTime":"0","summary":"三叶草生物-B于本报告期内录得收入人民币3,505千元，相比2024年度的人民币38,419千元有所下降。其他收入及收益在2025年和2024年分别为人民币54,098千元与人民币97,215千元，销售及分销开支分别达人民币5,070千元与人民币19,705千元，行政开支则为人民币66,332千元与人民币75,172千元。研发开支主要用于临床试验及相关雇员开支，两年分别为人民币182,338千元及人民币183,387千元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02197"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1105190361","title":"异动解读 | 三叶草生物-B盘中大涨6.99%，RSV疫苗重复接种试验获积极数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1105190361","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1105190361?lang=zh_cn&edition=full","pubTime":"2026-03-25 09:35","pubTimestamp":1774402558,"startTime":"0","endTime":"0","summary":"三叶草生物-B今日盘中股价大涨6.99%，引起了市场的广泛关注。消息面上，公司宣布其呼吸道合胞病毒融合前F蛋白候选疫苗于美国开展的I期临床试验取得额外积极数据。数据显示，SCB-1019异源重复接种组的RSV中和抗体几何平均滴度呈现约60–80%的上升趋势，且有望将抗体水平恢复至首剂接种后峰值的约120%–135%，表现优于同源重复接种。目前在美国，超过40%的符合RSV疫苗接种资格的老年人曾接种过首针，但首剂保护效力会逐渐下降。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02197"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622014639","title":"三叶草生物-B(02197)公布针对老年人群RSV疫苗重复接种的美国I期临床试验获得更多积极数据","url":"https://stock-news.laohu8.com/highlight/detail?id=2622014639","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622014639?lang=zh_cn&edition=full","pubTime":"2026-03-25 07:53","pubTimestamp":1774396434,"startTime":"0","endTime":"0","summary":"智通财经APP讯，三叶草生物-B 发布公告，其呼吸道合胞病毒融合前F蛋白候选疫苗于美国开展的I期临床试验取得额外积极数据。该临床试验针对的老年受试者于入组前至少两个流行季曾接种过GSK RSV疫苗AREXVY，并以头对头方式比较SCB-1019与AREXVY用于重复接种的效果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1418440.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","159646","02197"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621742895","title":"明德生物业绩预告修正后“变脸”；三叶草生物与全球疫苗免疫联盟和解 | 医药早参","url":"https://stock-news.laohu8.com/highlight/detail?id=2621742895","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621742895?lang=zh_cn&edition=full","pubTime":"2026-03-23 07:00","pubTimestamp":1774220407,"startTime":"0","endTime":"0","summary":"丨2026年3月23日星期一丨NO.1三叶草生物与全球疫苗免疫联盟就仲裁事项达成和解3月22日，三叶草生物发布公告，称三叶草香港与全球疫苗免疫联盟已订立和解协议，据此，此前仲裁将获得全面及最终解决，而全球疫苗免疫联盟就该仲裁向三叶草香港提出的所有申索，将于支付有关款项后获撤回及解除。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202603233679868895.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603233679868895.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["002932","BK1515","BK1574","BK1161","BK0239","02197","09939","159646","159938"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621494717","title":"三叶草生物-B(02197)：三叶草香港与全球疫苗免疫联盟已订立和解协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2621494717","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621494717?lang=zh_cn&edition=full","pubTime":"2026-03-22 21:24","pubTimestamp":1774185869,"startTime":"0","endTime":"0","summary":"三叶草香港与全球疫苗免疫联盟已于2026年3月22日订立和解协议，据此，该仲裁将获得全面及最终解决，而全球疫苗免疫联盟就该仲裁向三叶草香港提出的所有申索，将于支付下文所载的前期款项后获撤回及解除。三叶草香港订立和解协议仅出于商业考虑。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1417093.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02197","BK1161","159646"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619050450","title":"中科信息：3月13日董事王晓东减持股份合计1.05万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2619050450","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619050450?lang=zh_cn&edition=full","pubTime":"2026-03-16 20:01","pubTimestamp":1773662486,"startTime":"0","endTime":"0","summary":"证券之星消息，根据3月16日市场公开信息、上市公司公告及交易所披露数据整理，中科信息最新董监高及相关人员股份变动情况：2026年3月13日公司董事王晓东共减持公司股份1.05万股，占公司总股本为0.0035%。变动期间公司股价上涨0.16%，3月13日当日收盘报31.28元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031600031652.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0231","02197","300678","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619199464","title":"三叶草生物-B(02197.HK)拟3月25日举行董事会会议以审批年度业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=2619199464","media":"中金财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619199464?lang=zh_cn&edition=full","pubTime":"2026-03-13 19:07","pubTimestamp":1773400021,"startTime":"0","endTime":"0","summary":"格隆汇3月13日丨三叶草生物-B(02197.HK)公告，公司将于2026年3月25日(星期三)举行董事会会议，藉以(其中包括)考虑及批准公司及其附属公司截至2025年12月31日止年度全年业绩及其发布，并考虑建议派付末期股息(如有)。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260313/32067231.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["02197","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618189528","title":"三叶草生物-B盘中异动 早盘股价大涨5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618189528","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618189528?lang=zh_cn&edition=full","pubTime":"2026-03-12 09:30","pubTimestamp":1773279006,"startTime":"0","endTime":"0","summary":"2026年03月12日早盘09时30分，三叶草生物-B股票出现异动，股价大幅拉升5.09%。截至发稿，该股报2.270港元/股，成交量13.3万股，换手率0.01%，振幅2.78%。三叶草生物-B股票所在的生物技术行业中，整体涨幅为0.99%。其相关个股中，三叶草生物-B、百济神州、MIRXES-B涨幅较大，振幅较大的相关个股有三叶草生物-B、翰思艾泰-B、加科思-B，振幅分别为2.78%、2.47%、2.40%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260312093006a462745a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260312093006a462745a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02197"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618969561","title":"三叶草生物-B盘中异动 股价大涨5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618969561","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618969561?lang=zh_cn&edition=full","pubTime":"2026-03-10 09:43","pubTimestamp":1773107031,"startTime":"0","endTime":"0","summary":"2026年03月10日早盘09时43分，三叶草生物-B股票出现波动，股价快速上涨5.26%。截至发稿，该股报2.000港元/股，成交量24.9万股，换手率0.02%，振幅5.79%。资金方面，该股资金流入29.9125万港元，流出6.08万港元。三叶草生物-B股票所在的生物技术行业中，整体涨幅为1.93%。其相关个股中，科济药业-B、百奥赛图-B、康方生物涨幅较大，振幅较大的相关个股有轩竹生物-B、科济药业-B、百奥赛图-B，振幅分别为13.65%、11.35%、11.12%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260310094351a45cecc3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260310094351a45cecc3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02197"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1140357592","title":"三叶草生物-B（02197）2月股份变动月报，股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1140357592","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1140357592?lang=zh_cn&edition=full","pubTime":"2026-03-05 17:22","pubTimestamp":1772702565,"startTime":"0","endTime":"0","summary":"三叶草生物制药有限公司于2026年3月5日发布截至2026年2月28日的月度证券变动情况。公告显示，公司注册股本维持在2,000,000,000股，面值每股USD 0.0001，合计USD 200,000，与上月保持一致。公司本月末已发行股份总数为1,298,037,427股，与上月底持平。本月内未见任何新增发行、股份购回或注销活动，库藏股份数量仍为零，未发生变化。公告由公司董事梁朋签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"7babad1b4c042890cc8c6c387e110b44","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02197"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616510399","title":"三叶草生物-B03月02日主力净流出60.3万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2616510399","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616510399?lang=zh_cn&edition=full","pubTime":"2026-03-02 16:15","pubTimestamp":1772439321,"startTime":"0","endTime":"0","summary":"03月02日, 三叶草生物-B股价跌4.08%，报收1.88元，成交金额641.3万元，换手率0.26%，振幅4.59%，量比0.62。三叶草生物-B今日主力资金净流出60.3万元，上一交易日主力净流出0万元。该股近5个交易日下跌15.32%，主力资金累计净流出26.2万元；近20日主力资金累计净流出840.3万元，其中净流出天数为10日。该股主力净额占比0.02%，港股市场排名2480/2720。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260302161623a730ae27&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260302161623a730ae27&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02197"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614003041","title":"三叶草生物-B02月26日主力净流出62.7万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2614003041","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614003041?lang=zh_cn&edition=full","pubTime":"2026-02-26 16:15","pubTimestamp":1772093740,"startTime":"0","endTime":"0","summary":"02月26日, 三叶草生物-B股价跌8.61%，报收1.91元，成交金额3022.2万元，换手率1.21%，振幅11.96%，量比6.91。三叶草生物-B今日主力资金净流出62.7万元，上一交易日主力净流入153.3万元。该股近5个交易日下跌13.64%，主力资金累计净流出31.1万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流出852.0万元，其中净流出天数为10日。该股主力净额占比0.03%，港股市场排名2478/2718。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260226161845a7218869&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260226161845a7218869&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02197"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614035031","title":"三叶草生物-B02月25日主力净流入153.3万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2614035031","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614035031?lang=zh_cn&edition=full","pubTime":"2026-02-25 16:15","pubTimestamp":1772007313,"startTime":"0","endTime":"0","summary":"02月25日，三叶草生物-B股价收平报2.09元，成交金额529.0万元，换手率0.19%，振幅3.35%，量比1.15。三叶草生物-B今日主力资金净流入153.3万元，上一交易日主力净流出56.5万元。该股近5个交易日下跌5.00%，主力资金累计净流入31.6万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流出715.5万元，其中净流出天数为9日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260225161539a4c6602a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260225161539a4c6602a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02197","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614475057","title":"三叶草生物-B盘中异动 早盘大幅下挫5.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614475057","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614475057?lang=zh_cn&edition=full","pubTime":"2026-02-24 10:59","pubTimestamp":1771901947,"startTime":"0","endTime":"0","summary":"2026年02月24日早盘10时59分，三叶草生物-B股票出现波动，股价快速下挫5.41%。截至发稿，该股报2.100港元/股，成交量91.4万股，换手率0.07%，振幅4.95%。资金方面，该股资金流入45.778万港元，流出114.766万港元。三叶草生物-B股票所在的生物技术行业中，整体跌幅为2.13%。其相关个股中，帝王国际投资、基石药业-B、中生北控生物科技涨幅较大，振幅较大的相关个股有MIRXES-B、科笛-B、百奥赛图-B，振幅分别为21.50%、14.40%、12.29%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260224105907a4c11253&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260224105907a4c11253&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02197","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1196999731","title":"三叶草生物制药（02197）1月股份变动月报显示增发200,875股","url":"https://stock-news.laohu8.com/highlight/detail?id=1196999731","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1196999731?lang=zh_cn&edition=full","pubTime":"2026-02-04 16:44","pubTimestamp":1770194664,"startTime":"0","endTime":"0","summary":"三叶草生物制药有限公司于2026年2月4日披露截至2026年1月31日的股份变动月报表。公告显示，公司注册股本维持在2,000,000,000股普通股，面值每股USD 0.0001，总额USD 200,000。根据披露的期权计划信息，首次公开发售前购股权计划行使157,500股，首次公开发售后购股权计划行使43,375股，合计行使200,875股。截至本月底，前述期权计划分别余数1,506,817股及32,655,480股可予发行或转让。公司确认截至2026年1月31日相关股本及发行情况符合要求，股本规模保持稳定。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02197"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cloverbiopharma.com","stockEarnings":[{"period":"1week","weight":0.0364},{"period":"1month","weight":0.5489},{"period":"3month","weight":0.2025},{"period":"6month","weight":-0.0404},{"period":"1year","weight":11.7803},{"period":"ytd","weight":0.2179}],"compareEarnings":[{"period":"1week","weight":0.0105},{"period":"1month","weight":-0.0253},{"period":"3month","weight":-0.0464},{"period":"6month","weight":-0.0746},{"period":"1year","weight":0.0825},{"period":"ytd","weight":-0.0201}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"三叶草生物制药有限公司是一家主要从事创新型疫苗的研发、生产和商业化的投资控股公司。该公司的产品及候选疫苗包括呼吸道合胞病毒（RSV）疫苗（SCB-1019）、四价季节性流感疫苗AdimFlu-S、SCB-219M、新冠疫苗等。该公司依托Trimer-Tag技术平台开展可解决未满足需求的创新疫苗的研发（R&D），专注于建立呼吸道疫苗专营权，并在儿科疫苗市场创立业务。Trimer-Tag技术平台是一个基于天然依赖三聚体化功能的靶点用于研制重组蛋白疫苗的产品开发平台。该公司在国内和国外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0,"avgChangeRate":-0.113925},{"month":2,"riseRate":0.4,"avgChangeRate":0.011169},{"month":3,"riseRate":0.2,"avgChangeRate":-0.104268},{"month":4,"riseRate":0.4,"avgChangeRate":-0.036345},{"month":5,"riseRate":0.5,"avgChangeRate":-0.108229},{"month":6,"riseRate":0.5,"avgChangeRate":0.010941},{"month":7,"riseRate":0.5,"avgChangeRate":0.152709},{"month":8,"riseRate":0.5,"avgChangeRate":0.089271},{"month":9,"riseRate":0.5,"avgChangeRate":0.326004},{"month":10,"riseRate":0,"avgChangeRate":-0.070872},{"month":11,"riseRate":0.75,"avgChangeRate":0.569272},{"month":12,"riseRate":0.2,"avgChangeRate":-0.160916}],"exchange":"SEHK","name":"三叶草生物-B","nameEN":"CLOVER BIO-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.40.0","shortVersion":"4.40.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"三叶草生物-B(02197)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供三叶草生物-B(02197)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"三叶草生物-B,02197,三叶草生物-B股票,三叶草生物-B股票老虎,三叶草生物-B股票老虎国际,三叶草生物-B行情,三叶草生物-B股票行情,三叶草生物-B股价,三叶草生物-B股市,三叶草生物-B股票价格,三叶草生物-B股票交易,三叶草生物-B股票购买,三叶草生物-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"三叶草生物-B(02197)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供三叶草生物-B(02197)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}